Global
Regions
WHO Regional websites
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
العربية
中文
English
français
русский
español
Home
Health Topics
All topics »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Resources »
Data
Fact sheets
Facts in pictures
Publications
Questions & answers
Popular »
Ebola virus disease
Nutrition
Hepatitis
Top 10 causes of death
World Blood Donor Day»
Countries
All countries »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Regions »
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
WHO in countries »
Overview
Statistics
Cooperation strategies
Democratic Republic of the Congo »
WHO
©
Credits
Newsroom
All news »
News releases
Statements
Notes for media
Commentaries
Events
Feature stories
Speeches
Spotlights
Newsletters
Infographics
Media distribution list
Headlines »
Campaigns and initiatives »
Year of the Nurse and the Midwife 2020
Emergencies
Focus on »
Bangladesh Rohingya
Democratic Republic of the Congo
Ebola virus disease
Iraq
Nigeria
Novel Coronavirus (2019-nCoV)
Somalia
South Sudan
Syrian Arab Republic
Yemen
All emergencies »
Latest »
By country
By disease
Disease Outbreak News
Weekly Epidemiological Record
Health Emergency Highlights
Travel advice
Contact
WHO in emergencies »
Funding
Training
Partners & networks
Research & development
Attacks on health care
Health cluster
Public Health Emergency Dashboard
Novel coronavirus (COVID-19) »
Getty images
©
Credits
About Us
About WHO »
Our values
Who we are
What we do
Where we work
Programmes
Collaboration and partnerships
Ethics
Director-General
Contact us »
Governing bodies »
World Health Assembly
Executive Board
Accountability »
General Programme of Work
Programme Budget Portal
Invest in WHO
Financial reports
Investment Case
Better health for everyone »
WHO
©
Credits
Home
/
Newsroom
/
Feature stories
/
Detail
/
New hope with Ebola drug trial
New hope with Ebola drug trial
1 January 2019
- Select language -
العربية
中文
français
русский
español
Want to read more?
Subscribe to newsletter →
